Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
- Man rushes stage at 2nd Congressional District debate to shout ‘vaccines cause autism’ on September 18, 2018 at 7:48 pm
ST. GEORGE, Utah -- As Republican incumbent congressman Chris Stewart was giving his closing statement, a man rushed the stage and grabbed his microphone. "Vaccines cause autism!" the man shouted ... […]
- WA autism program a ‘resounding success’ as more schools jump on board on September 18, 2018 at 6:49 pm
Seven more schools in Western Australia will offer a specialist learning program for students with autism spectrum disorder from 2019. Students with autism will be able to have a seamless transition f... […]
- Sixth grader with autism needs a trumpet for school band on September 18, 2018 at 10:39 am
An 11-year-old in sixth grade at C.S. Porter Middle school is on the autism spectrum. He really wants to play in his school's band this year but his family does not have the funds to purchase or ... […]
- Watch: Anti-Vaxxer Hijacks Microphone At Utah Congressional Debate: 'Vaccines Cause Autism' on September 18, 2018 at 9:19 am
An anti-vaxxer jumped onto the stage of a Utah congressional candidate debate Monday and yelled "vaccines cause autism" into the microphone as the GOP candidate gave his closing remarks. Corbin McMill... […]
- Autism Walk aims at raising awareness and funds at Westfield's Stanley Park Sept. 22 on September 18, 2018 at 9:09 am
WESTFIELD - Thousands of families affected by autism will gather at Stanley Park Sept. 22 to raise awareness of Autism Spectrum Disorders - as well as funds - through the Western New England Autism Sp... […]
- Alzheimer's or Not; DBS for Autism; Dopamine-Tracking Sensors on September 18, 2018 at 8:40 am
Science magazine looks at deep brain stimulation for severely autistic patients. The 18 F-labeled PET imaging agent flortaucipir met its two primary endpoints-- predicting brain tau pathology and pred... […]
- J.C. Penney schedules a shopping event for children with autism on September 18, 2018 at 7:50 am
J.C. Penney is bringing one of its shopping events for school-aged children with autism to Frisco. The back-to-school shopping event is Saturday at its store in Stonebriar Centre from 9 a.m. to 11 a.m ... […]
- Exploring autism's secrets: Duluth family enrolls in largest ever research project that seeks to understand a complex disorder on September 18, 2018 at 3:23 am
When Steve and Jeannine Morgan heard about the SPARK for Autism study, the timing wasn't the best. It was December 2016 and the couple, who live in the Woodland neighborhood with sons Dylan and Henry ... […]
- Suspect sought for sexually assaulting man with autism in San Juan Capistrano library bathroom on September 17, 2018 at 11:30 pm
Authorities are searching for a man suspected of sexually assaulting another man with autism in the bathroom of an Orange County library. The incident happened around 1:15 p.m. April 16, when a ... […]
- Surveillance Images Released of Suspect in Sexual Assault of Man With Autism at San Juan Capistrano Library on September 17, 2018 at 8:11 pm
Authorities on Monday released images from surveillance footage showing an individual suspected of sexually assaulting a man with autism inside a restroom at the San Juan Capistrano Public Library. […]
via Google News and Bing News